CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-15 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −719 | $546.56 | $393K | 45,172 |
| 2026-10-15 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise · Stock Option 10b5-1 | −8,300 | 30,940 | ||
| 2026-10-15 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-10-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −281 | $540.48 | $152K | 333,662 |
| 2026-10-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,163 | $541.59 | $630K | 332,499 |
| 2026-10-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −456 | $542.68 | $247K | 332,043 |
| 2026-10-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −371 | $543.39 | $202K | 331,672 |
| 2026-10-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −269 | $544.75 | $147K | 331,403 |
| 2026-10-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −825 | $545.87 | $450K | 330,578 |
| 2026-10-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −601 | $546.94 | $329K | 329,977 |
| 2026-10-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,166 | $547.83 | $1.2M | 327,811 |
| 2026-10-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,039 | $548.89 | $1.1M | 325,772 |
| 2026-10-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,009 | $549.76 | $555K | 324,763 |
| 2026-10-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −200 | $550.72 | $110K | 324,563 |
| 2026-10-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $551.50 | $66K | 324,443 |
| 2026-10-15 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 223,910 | ||
| 2026-10-14 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-10-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $526.07 | $21K | 333,903 |
| 2026-10-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $530.09 | $85K | 333,743 |
| 2026-10-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $531.19 | $64K | 333,623 |
Page 18 of 120 · 2,391 trades